Skip to content

Ashland ASH Life Sciences — PP&E (Net)

Other segment segments

Specialty Additives
$468M
Unallocated And Other
$102M
Personal Care And Household
$95M
Intermediates And Solvents
$30M

Similar metrics at other companies

Kiniksa Pharmaceuticals International, plc logo
KNSAPharmaceutical — PP&E (Net)
$1.99M
Bruker logo
BRKRPP&E (Net)
$719.6M+4.4%
ImmunityBio, Inc. logo
IBRXPP&E (Net)
$112.79M-16.6%
Idexx Laboratories logo
IDXXOther — PP&E (Net)
$9.95M+29.1%
DNOW logo
DNOWCA — PP&E (Net)
$9M-10.0%
Axsome Therapeutics logo
AXSMPP&E (Net)
$567K-26.6%

Other financials

Income statement

See full
Revenue$482.0M+0.6%
Gross profit$147.0M0.0%
Operating income$39.0M-23.5%
Net income$16.0M-48.4%
EPS (diluted)$0.34-47.7%

Balance sheet

See full
Cash & equivalents$343.0M+104%
Total debt$1.5B-0.6%
Total equity$1.9B-27.1%
Total assets$4.5B-14.0%

Cash flow

See full
Operating cash flow$50.0M+456%
CapEx$17.0M-19.0%
Free cash flow$33.0M+375%

Valuation

See full
Market cap$2.93B-9.0%
Enterprise value$4.06B-10.6%
P/S1.6×0.0×

Profitability

See full
Gross margin30%-1.7pp
Operating margin-37.3%
Net margin-40.8%-48.8pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity-33.4%-38.5pp
Debt / equity0.8×+0.2×
Current ratio3.1×+0.7×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Ashland’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ashland's life sciences — pp&e (net).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ashland's life sciences — PP&E (net)?
Ashland (ASH) reported life sciences — PP&E (net) of $468M in Q1 2026.
What does life sciences — PP&E (net) mean?
This represents the book value of the physical infrastructure and manufacturing assets held by the Life Sciences segment, net of accumulated depreciation. It indicates the segment's investment in production capacity and long-term operational capabilities. Changes in this balance reflect capital expenditure trends and the aging profile of the segment's manufacturing footprint.